tiprankstipranks
Harmony Biosciences price target raised to $33 from $31 at BofA
PremiumThe FlyHarmony Biosciences price target raised to $33 from $31 at BofA
1M ago
Cautious Outlook: Sell Rating for Harmony Biosciences Due to Pipeline Concerns and Generic Competition Risks
Premium
Ratings
Cautious Outlook: Sell Rating for Harmony Biosciences Due to Pipeline Concerns and Generic Competition Risks
1M ago
Harmony Biosciences Reports Strong 2024 Financial Results
Premium
Company Announcements
Harmony Biosciences Reports Strong 2024 Financial Results
1M ago
Concerns Over Harmony Biosciences: FDA Setback, Patent Risks, and High-Risk Pipeline
PremiumRatingsConcerns Over Harmony Biosciences: FDA Setback, Patent Risks, and High-Risk Pipeline
1M ago
Harmony Biosciences: Buy Rating Affirmed Despite FDA Setback, Strong Growth Potential in Pitolisant Franchise and Pipeline Opportunities
Premium
Ratings
Harmony Biosciences: Buy Rating Affirmed Despite FDA Setback, Strong Growth Potential in Pitolisant Franchise and Pipeline Opportunities
1M ago
Strategic Focus on Next-Gen Formulations Supports Buy Rating for Harmony Biosciences Despite Short-term Setbacks
Premium
Ratings
Strategic Focus on Next-Gen Formulations Supports Buy Rating for Harmony Biosciences Despite Short-term Setbacks
1M ago
Harmony Biosciences price target raised to $32 from $31 at BofA
PremiumThe FlyHarmony Biosciences price target raised to $32 from $31 at BofA
2M ago
Harmony Biosciences Projects Strong Revenue Growth for 2025
Premium
Company Announcements
Harmony Biosciences Projects Strong Revenue Growth for 2025
2M ago
Harmony Biosciences sees Q4 revenue $201M, consensus $198.6M
Premium
The Fly
Harmony Biosciences sees Q4 revenue $201M, consensus $198.6M
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100